Cisplatin-encapsulated TRAIL-engineered exosomes from human chorion-derived MSCs for targeted cervical cancer therapy
Miaomiao Ye, Tingxian Liu, Liqing Miao, Huihui Ji, Zhihui Xu, Huihui Wang, Jian’an Zhang, Xueqiong Zhu · 2024
Read Cisplatin-encapsulated TRAIL-engineered exosomes from human chorion-derived MSCs for targeted cervical cancer therapy by Miaomiao Ye, Tingxian Liu, Liqing Miao, Huihui Ji, Zhihui Xu, Huihui Wang, Jian’an Zhang, Xueqiong Zhu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11536590.txt.
Description
Cervical cancer that has spread is often treated with cisplatin, a strong chemotherapy drug with harsh side effects. Miaomiao Ye and seven co-authors package that drug inside exosomes, tiny parcels shed by stem cells taken from human chorion tissue. The cells were first engineered so their exosomes also carry TRAIL, a protein that pushes cancer cells into programmed death through surface receptors the parcels can reach.
In cell tests, the loaded parcels slowed the growth of two cervical cancer lines and raised cell death more than the drug or the TRAIL parcels alone. In tumor-bearing mice, they shrank tumors, acting through a stress pathway that switched on cell death while suppressing a survival protein, and they showed good safety. The authors present the combined parcels as a promising chemo-gene therapy.
Catalog record
| CREATOR | Miaomiao Ye, Tingxian Liu, Liqing Miao, Huihui Ji, Zhihui Xu, Huihui Wang, Jian’an Zhang, Xueqiong Zhu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |